Financial reports
10-K
2023 FY
Annual report
15 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
21 Aug 23
NT 10-Q
Notice of late quarterly filing
15 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
10 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
10-K
2021 FY
Annual report
30 Mar 22
Current reports
8-K
Regulation FD Disclosure
19 Apr 24
8-K
Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering
19 Apr 24
8-K
Entry into a Material Definitive Agreement
18 Apr 24
8-K
Entry into a Material Definitive Agreement
1 Apr 24
8-K
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Results
18 Mar 24
8-K
Entry into a Material Definitive Agreement
12 Mar 24
8-K
Amendments to Articles of Incorporation or Bylaws
1 Mar 24
8-K
Regulation FD Disclosure
28 Feb 24
8-K
Unregistered Sales of Equity Securities
12 Feb 24
8-K
Results of Operations and Financial Condition
7 Feb 24
Registration and prospectus
424B4
Prospectus supplement with pricing info
17 Apr 24
S-1/A
IPO registration (amended)
15 Apr 24
S-1/A
IPO registration (amended)
8 Apr 24
S-1/A
IPO registration (amended)
2 Apr 24
S-1/A
IPO registration (amended)
29 Mar 24
D
$65.00 k in equity, sold $32.50 k, 1 investor
20 Mar 24
D
$3.50 mm in debt / options / securities to be acquired, sold $3.50 mm, 1 investor
20 Mar 24
D
$341.25 k in equity, sold $195.00 k, 1 investor
20 Mar 24
D
$10.00 k in equity, sold $10.00 k, 1 investor
20 Mar 24
D
$1.00 mm in debt / options / securities to be acquired, sold $1.00 mm, 1 investor
20 Mar 24
Other
EFFECT
Notice of effectiveness
17 Apr 24
EFFECT
Notice of effectiveness
22 Jan 24
CORRESP
Correspondence with SEC
17 Jan 24
CORRESP
Correspondence with SEC
16 Jan 24
UPLOAD
Letter from SEC
10 Jan 24
CORRESP
Correspondence with SEC
8 Jan 24
UPLOAD
Letter from SEC
21 Dec 23
CORRESP
Correspondence with SEC
12 Dec 23
UPLOAD
Letter from SEC
19 Oct 23
SEC STAFF
SEC staff action: Order
8 Aug 23
Ownership
4
James A Schoeneck
22 Apr 24
3
David LaPre
12 Mar 24
SC 13G/A
683 Capital Management, LLC
14 Feb 24
SC 13G/A
First Light Acquisition Group, LLC
14 Feb 24
SC 13G/A
First Trust Capital Management L.P.
12 Feb 24
SC 13G/A
Woodline Partners LP
12 Feb 24
SC 13G/A
SPRING CREEK CAPITAL LLC
9 Feb 24
SC 13G/A
Polar Asset Management Partners Inc.
9 Feb 24
4
Alfonso G Zulueta
4 Jan 24
4
Alan R. Stewart
4 Jan 24